Cargando…
Performance of preoperative plasma tumor markers HE4 and CA125 in predicting ovarian cancer mortality in women with epithelial ovarian cancer
Clinical utility of new biomarkers often requires the identification of their optimal threshold. This external validation study was conducted to assess the performance of the preoperative plasma tumor markers HE4 and CA125 optimal cut-offs to predict cancer mortality in women with epithelial ovarian...
Autores principales: | Furrer, Daniela, Grégoire, Jean, Turcotte, Stéphane, Plante, Marie, Bachvarov, Dimcho, Trudel, Dominique, Têtu, Bernard, Douville, Pierre, Bairati, Isabelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586345/ https://www.ncbi.nlm.nih.gov/pubmed/31220149 http://dx.doi.org/10.1371/journal.pone.0218621 |
Ejemplares similares
-
Correction to: HtrA1 expression and the prognosis of high-grade serous ovarian carcinoma: a cohort study using digital analysis
por: Gagné, Andréanne, et al.
Publicado: (2018) -
HtrA1 expression and the prognosis of high-grade serous ovarian carcinoma: a cohort study using digital analysis
por: Gagné, Andréanne, et al.
Publicado: (2018) -
Global gene expression analysis of early response to chemotherapy treatment in ovarian cancer spheroids
por: L'Espérance, Sylvain, et al.
Publicado: (2008) -
Symptoms, CA125 and HE4 for the preoperative prediction of ovarian malignancy in Brazilian women with ovarian masses
por: Pitta, Denise da Rocha, et al.
Publicado: (2013) -
HE4, CA-125, and cystic ovarian mass
por: Wiwanitkit, Viroj
Publicado: (2012)